The International Pharmaceutical Federation (FIP) has offered a new resource to help countries self-assess readiness of their regulations to enable
pharmacist-delivered vaccination services and, where needed, to implement such regulations.
Developed by FIP's Regulators Advisory Group, it covers broad pharmacist-led roles related to vaccination from supply chain management to administration and
prescribing.
"This new resource from FIP is based on the experiences of professional regulators in countries where pharmacy-led vaccination has been successfully introduced
and regulated. With it, we aim to support regulators, policymakers and national organisations in developing strategies or enabling regulatory frameworks in
countries where the pharmacy workforce has a limited role in vaccination strategies so that it can contribute further to the global imperative of improving
immunisation coverage," said Brett Simmonds, group chair.
The "Pharmacy-led vaccination services: Regulatory self-assessment and implementation tool" aims to help identify strengths and areas for improvement in order to
inform vaccination policy and planning efforts.
A three-wheeled wheelchair was built in 1655 or 1680 by a disabled German man, Stephan Farffler, who wanted to be able to maintain his mobility. Since he was a watch-maker, he was able to create a vehicle that was powered by hand cranks.
In 1789, two French inventors developed a three wheeled vehicle, powered by pedals; They called it the tricycle.
19th century tricycle used in Iran
In 1818, British inventor Denis Johnson patented his approach to designing tricycles.[clarification needed] In 1876, James Starley developed the Coventry Lever Tricycle, which used two small wheels on the right side and a large drive wheel on the left side; power was supplied by hand levers. In 1877, Starley developed a new vehicle he called the Coventry Rotary, which was "one of the first rotary chain drive tricycles." Starley's inventions started a tricycling craze in Britain; by 1879, there were " twenty types of tricycles and multi-wheel cycles ... produced in Coventry, England, and by 1884, there were over 120 different models produced by 20 manufacturers." The first front steering tricycle was manufactured by The Leicester Safety Tricycle Company of Leicester, England in 1881 which was brought to the market in 1882 costing £18. They also developed a folding tricycle at the same time.Buy online Tricycle for handicapped and disabled at lowest price and cheap cost in india from wheelchair india online shopping store of Tricycle manufacturer, distributor, dealer and supplier of variety of Tricycles at low price in india for handicapped and disability product like Disabled Tricycle Deluxe Double Hand Drive, Tricycle Deluxe Single Hand Drive, Tricycle Standard Double Hand Drive, Tricycle Regular Single Hand Drive, Standard Single Hand Drive Tricycle, along with that we offer huge discount.
Tricycles were used by riders who did not feel comfortable on the high wheelers, such as women who wore long, flowing dresses. In the UK, upright tricycles are sometimes referred to as "ba
A three-wheeled wheelchair was built in 1655 or 1680 by a disabled German man, Stephan Farffler, who wanted to be able to maintain his mobility. Since he was a watch-maker, he was able to create a vehicle that was powered by hand cranks.
In 1789, two French inventors developed a three wheeled vehicle, powered by pedals; They called it the tricycle.
19th century tricycle used in Iran
In 1818, British inventor Denis Johnson patented his approach to designing tricycles.[clarification needed] In 1876, James Starley developed the Coventry Lever Tricycle, which used two small wheels on the right side and a large drive wheel on the left side; power was supplied by hand levers. In 1877, Starley developed a new vehicle he called the Coventry Rotary, which was "one of the first rotary chain drive tricycles." Starley's inventions started a tricycling craze in Britain; by 1879, there were " twenty types of tricycles and multi-wheel cycles ... produced in Coventry, England, and by 1884, there were over 120 different models produced by 20 manufacturers." The first front steering tricycle was manufactured by The Leicester Safety Tricycle Company of Leicester, England in 1881 which was brought to the market in 1882 costing £18. They also developed a folding tricycle at the same time.
Tricycles were used by riders who did not feel comfortable on the high wheelers, such as women who wore long, flowing dresses. In the UK, upright tricycles are sometimes referred to as "barrows". Many trike enthusiasts ("trikies") in the UK belong to the Tricycle Association, formed in 1929. They participate in day rides, tours and time trials. Massed start racing of upright tricycles is limited to one or two criteriums such as in Bungay, Suffolk each year.
With the UK General Election set for 4 July, pharmacy bodies are actively engaging with all political parties to secure support for the community pharmacy
sector. They are pressing parties to address urgent issues such as pharmacy closures and medicine shortages.
"The upcoming general election is a critical opportunity for us to strengthen supporters of community pharmacy in readiness for the new Parliament," said Janet
Morrison, chief executive of Community Pharmacy England (CPE).
She stressed the need for unity within the sector in advocating for community pharmacy and raising awareness of the issues with election candidates from all parties.
As the general election approaches, CPE has called upon all political parties to support pharmacies by "introducing a long-term sustainable funding model and
reviewing the medicines supply chain, including much-needed short-term relief measures."
The recent announcement that Royal Mail will be partnering with distance selling pharmacy (DSP) giant pharmacy2U highlights how standards of regulatory
enforcement are being ignored to accommodate the DSP model.
The brunt of these double standards hinges around the levelling down of temperature enforcement standards by the Medicines and Healthcare products Regulatory
Agency (MHRA) which demands mapping must be audited from the point of dispensing to the patient.
The MHRA has a well recognised duty to ensure medicines reach patients in a safe condition. The current anomaly appears to turn a blind eye to this step in the
supply chain at the point the wholesaler releases goods to the pharmacy hub.
Equally the training on delivering medicines safely and effectively direct to patients should apply fully to all hubs including DSPs. Why is it that DSPs are being
treated differently to bricks and mortar pharmacies? It's essentially the same patients receiving the same medicines from the same wholesalers.
A further regulatory disparity exists around how parcels must be "tracked and signed for" to be reasonably certain medicines are delivered into the hand of the
intended recipient, as per existing regulations.
Clearly an untracked, unsigned package cannot be guaranteed to finish in the hands of the intended recipient.
There is a very real possibility that such omission could lead to community pharmacy closures which will, in turn, lead to unemployment and a reduction in the
care services. At a time when integrated care systems have just gone live, the removal of vital support services leading to further inequalities is the wrong
message for both providers and patients alike.
Essential Pharma, an international speciality pharma group, has procured an establishment and manufacturing licences in Switzerland and Malta.
Following a successful inspection by Swissmedic, the company has been granted an establishment licence in Switzerland, which will allow the company to significantly
enhance its supply chain efficiency for a wide range of important medicinal products. It will apply to transactions for both finished and unfinished pharmaceuticals,
allowing importing, exporting, wholesaling and trading abroad.
Essential Pharma has also received a manufacturing and importation authorisation (MIA) in Malta, following a successful Good Manufacturing Practice (GMP) inspection
by the Malta Medicines Authority.
The MIA will allow the company to import medicinal products into the European Union where manufacturing has taken place in a third country. This will allow greater
flexibility in how the business manages the flow of medicines across its territories.
These approvals strengthen the company's geographical expansion, improve its operational efficiencies, and enhance its offering as a global business partner. They
will also provide new strategic opportunities for the company and will play a fundamental role in driving value creation through functional improvements to scale
and productivity.
AAH Pharmaceuticals on Tuesday (November 15) announced the promotion of its commercial director David Bound to chief executive officer of the company.
In his 10 years in the company, Mr Bound has helped to drive growth across the AAH business, implementing new digital channels for customers, and developing
strategic partnerships with pharmaceutical manufacturers - drawing on from his vast experience in the healthcare industry, as well as in supply chain, operations,
and trading.
Commenting on his promotion, he said: "I'm delighted to be taking on this role at such a critical time for healthcare. There are many challenges affecting the
industry right now - from inflationary pressures to workforce issues - and I'm looking forward to tackling them head-on alongside my excellent team."
Bestway Healthcare has appointed Jeremy Meader as its new chief wholesale officer, following the retirement of Anup Sodha.
Meader would join the company in mid-November but is expected to officially assume his responsibilities from January 2, 2024.
He will lead Lexon, Bestway Medhub, Wardle's, Knights Fragrances, PI & Specials manufacturing and the wholesale supply chain.
Sodha, who co-founded the business 25 years ago, will continue to lead the company's wholesale business unit until 31 December 2023.
Commenting on his retirement, Sodhi said: "I am proud of what we achieved at Lexon, it has been a team effort and I am grateful to everyone who has helped as
we built a strong wholesale business.
Prime Minister, Rishi Sunak, has backed pharmacists to play a greater clinical role in the health and well-being of the nation, describing them
as "valuable and trusted" members of the community.
Pharmacists have faced a difficult year with 222 community pharmacies closing in just the first six months.
Boots alone will be closing 300 branches over the next 12 months.
Sunak, however, insisted that his government knows the "hard work of pharmacy teams", and that he wants to "enable them to do more to support the NHS."
Speaking at the annual Sigma Conference in London on Sunday (5 November), the prime minister reiterated that community pharmacy is in line for a much-needed
boost in funding.
"Earlier this year, the government announced plans for further investment of up to £645 million over the next few years to support the Pharmacy First service
for patients," Sunak said in a letter read out at the conference by Lord Dolar Popat.
"This means that community pharmacies will be able to assess patients and provide some options to protect them without a GP appointment."